ERLOTINIB

Generic: ERLOTINIB HYDROCHLORIDE

Armas Pharmaceuticals Inc.Manufacturer
ORALRoute
ERLOTINIB HYDROCHLORIDEActive Substance
2019-11-05Original Approval

ERLOTINIB is FDA application ANDA211960, sponsored by ADAPTIS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
DEATH
3,667 reports
2
DIARRHOEA
1,342 reports
3
RASH
1,323 reports
4
OFF LABEL USE
904 reports
5
MALIGNANT NEOPLASM PROGRESSION
892 reports
6
FATIGUE
721 reports
7
NAUSEA
697 reports
8
VOMITING
577 reports
9
DISEASE PROGRESSION
572 reports
10
DECREASED APPETITE
514 reports